Clinical application of TcGSA.

[1]  T. Muto,et al.  Predictors of successful hepatic resection: Prognostic usefulness of hepatic asialoglycoprotein receptor analysis , 2002, World Journal of Surgery.

[2]  M. Makuuchi,et al.  Receptor measurements via Tc-GSA kinetic modeling are proportional to functional hepatocellular mass. , 2001, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[3]  T. Kuroki,et al.  Clinical usefulness of scintigraphy with 99mTc-galactosyl-human serum albumin for prognosis of cirrhosis of the liver. , 1999, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[4]  N Tonami,et al.  Preoperative assessment of residual hepatic functional reserve using 99mTc-DTPA-galactosyl-human serum albumin dynamic SPECT. , 1999, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[5]  H. Sakahara,et al.  Asialoglycoprotein receptor scintigraphy in evaluation of auxiliary partial orthotopic liver transplantation. , 1999, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[6]  Y Bandai,et al.  Asialoglycoprotein receptor and hepatic blood flow using technetium-99m-DTPA-galactosyl human serum albumin. , 1997, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[7]  D. Vera,et al.  Evaluation of hepatocellular function by way of receptor‐mediated uptake of a technetium‐99m—labeled asialoglycoprotein analog , 1994, Hepatology.

[8]  S. Kawasaki,et al.  Surgery for small liver cancers. , 1993, Seminars in surgical oncology.

[9]  M. Kudo,et al.  Quantitative assessment of hepatocellular function through in vivo radioreceptor imaging with technetium 99m galactosyl human serum albumin , 1993, Hepatology.

[10]  M. Kudo,et al.  [Phase III multi-center clinical study on 99mTc-GSA, a new agent for functional imaging of the liver]. , 1992, Kaku igaku. The Japanese journal of nuclear medicine.

[11]  K Torizuka,et al.  [Phase II clinical study on 99mTc-GSA, a new agent for functional imaging of the liver]. , 1991, Kaku igaku. The Japanese journal of nuclear medicine.

[12]  S K Ha-Kawa,et al.  A quantitative model of technetium-99m-DTPA-galactosyl-HSA for the assessment of hepatic blood flow and hepatic binding receptor. , 1991, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[13]  P O Scheibe,et al.  Measurement of receptor concentration and forward-binding rate constant via radiopharmacokinetic modeling of technetium-99m-galactosyl-neoglycoalbumin. , 1991, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[14]  E. Woodle,et al.  Tc-NGA imaging in liver transplantation: preclinical studies. , 1987, Surgery.

[15]  Y. Tashiro,et al.  Hyperasialoglycoproteinemia in patients with chronic liver diseases and/or liver cell carcinoma: Asialoglycoprotein receptor in cirrhosis and liver cell carcinoma , 1984 .

[16]  K. Krohn,et al.  Tc-99m-galactosyl-neoglycoalbumin: in vivo characterization of receptor-mediated binding to hepatocytes. , 1984, Radiology.

[17]  D. M. Carlson,et al.  Measurement of circulating desialylated glycoproteins and correlation with hepatocellular damage. , 1974, The Journal of clinical investigation.

[18]  R. Pugh,et al.  Transection of the oesophagus for bleeding oesophageal varices , 1973, The British journal of surgery.

[19]  I. Sternlieb,et al.  Physical and chemical studies on ceruloplasmin. V. Metabolic studies on sialic acid-free ceruloplasmin in vivo. , 1968, The Journal of biological chemistry.

[20]  C. G. Child,et al.  Surgery and portal hypertension. , 1964, Major problems in clinical surgery.